5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | NEUTRAL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.75▲ | 2.75▲ | 2.75▲ | 2.63▲ | 2.87▼ |
MA10 | 2.76▼ | 2.74▲ | 2.71▲ | 2.75▼ | 2.30▲ |
MA20 | 2.75▲ | 2.69▲ | 2.65▲ | 2.88▼ | 2.23▲ |
MA50 | 2.71▲ | 2.63▲ | 2.68▲ | 2.27▲ | 6.41▼ |
MA100 | 2.64▲ | 2.76▼ | 2.88▼ | 2.30▲ | N/A |
MA200 | 2.76▼ | 2.88▼ | 2.55▲ | 5.26▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | 0.006▲ | 0.021▲ | -0.066▼ | 0.425▲ |
RSI | 53.338▲ | 60.198▲ | 58.407▲ | 53.346▲ | 43.967▼ |
STOCH | 25.926 | 73.578 | 72.026 | 24.097 | 70.026 |
WILL %R | -50.000 | -22.500▲ | -18.750▲ | -59.155 | -42.857 |
CCI | 27.990 | 57.974 | 92.256 | -41.392 | 68.228 |
MA | $ARTV Price Crossed Above MA(26) | Set Alert |
Wednesday, August 06, 2025 02:14 PM
First patient treated in company-sponsored global basket trial exploring AlloNK® + rituximab in refractory rheumatoid arthritis, Sjögren' ...
|
Saturday, July 19, 2025 07:48 AM
Ally Financial Inc. (NYSE:ALLY) Q2 2025 Earnings Call Transcript July 18, 2025 Ally Financial Inc. beats earnings expectations. Reported EPS is $0.99, expectations were $0.78. Operator: Good day ...
|
Monday, July 14, 2025 01:45 PM
About This EventArtiva Biotherapeutics (Nasdaq: ARTV), visits the Nasdaq MarketSite in Times Square. Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 2.68 | 2.81 | 2.61 | 2.75 | 63,500 |
14/08/25 | 2.63 | 2.75 | 2.56 | 2.70 | 36,000 |
13/08/25 | 2.48 | 2.69 | 2.48 | 2.67 | 59,900 |
12/08/25 | 2.57 | 2.67 | 2.46 | 2.47 | 112,600 |
11/08/25 | 2.72 | 2.75 | 2.51 | 2.56 | 51,600 |
08/08/25 | 2.69 | 2.99 | 2.63 | 2.76 | 72,300 |
07/08/25 | 2.79 | 2.92 | 2.63 | 2.64 | 57,000 |
06/08/25 | 3.08 | 3.08 | 2.84 | 2.87 | 76,800 |
05/08/25 | 3.02 | 3.09 | 2.93 | 3.08 | 34,700 |
04/08/25 | 2.88 | 3.15 | 2.775 | 3.01 | 95,300 |
|
|
||||
|
|
||||
|
|